Skip to main content

Epidemiology of Parkinson’s Disease

  • Conference paper
Neurology
  • 175 Accesses

Abstract

During the last three decades, there has been an increasingly productive interest in epidemiological research into Parkinson’s disease (PD); as a result, a number of descriptive and analytical epidemiological studies have been recently completed. Although the epidemiological profile of PD is not yet fully elucidated, these studies have appreciably advanced our knowledge of the epidemiological indices and natural course of PD, and furnished some clues relating to the unknown cause of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baumann RJ, Jameson HD, McKean HE, Haack DG, Weisberg LM (1980) Cigarette smoking and Parkinson’s disease. 1. A comparison of cases with matched neighbors. Neurology 30: 839–843

    PubMed  CAS  Google Scholar 

  2. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and syndrome of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415–455

    Article  PubMed  CAS  Google Scholar 

  3. Brewis M, Poskanzer DC, Rolland C, Miller H (1966) Neurological disease in an English city. Acta Neurol Scand [suppl 24]: 1–89

    Google Scholar 

  4. Dimsdale H (1946) Changes in the parkinsonian syndrome in the twentieth century. Q J Med 15: 155–170

    PubMed  CAS  Google Scholar 

  5. Dupont E (1977) Epidemiology of parkinsonism: the Parkinson investigation, Arhus, Denmark. In: Worm-Petersen J, Böttcher J (eds) Symposium on Parkinsonism. Merck, Sharp and Dohme, Denmark, pp 65–75

    Google Scholar 

  6. Duvoisin RC, Yahr MD (1965) Encephalitis and parkinsonism. Arch Neurol 12: 227–239

    PubMed  CAS  Google Scholar 

  7. Godwin-Austen RB, Lee PN, Marmot MG, Stern GM (1982) Smoking and Parkinson’s disease. J Neurol Neurosurg Psychiatry 45: 577–581

    Article  PubMed  CAS  Google Scholar 

  8. Gudmundsson KRA (1967) A clinical survey of Parkinsonism in Iceland. Acta Neurol Scand 43 [suppl 33]: 9–61

    Article  Google Scholar 

  9. Haack DG, Baumann RJ, McKean HE, Jameson HD, Turbek JA (1981) Nicotine exposure and Parkinson’s disease. Am J Epidemiol 114: 191–200

    PubMed  CAS  Google Scholar 

  10. Harada H, Nishikawa S, Takahashi K (1983) Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol 40: 151–154

    PubMed  CAS  Google Scholar 

  11. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17: 427–442

    PubMed  CAS  Google Scholar 

  12. Jenkins AC (1966) Epidemiology of Parkinsonism in Victoria. Med J Aust 2: 496–502

    PubMed  CAS  Google Scholar 

  13. Kessler II (1972) Epidemiologic studies of Parkinson’s disease. II. Hospital based survey. Am J Epidemiol 95: 308–318

    PubMed  CAS  Google Scholar 

  14. Kessler II (1972) Epidemiologic studies of Parkinson’s disease. III. A community based survey. Am J Epidemiol 96: 242–254

    PubMed  CAS  Google Scholar 

  15. Kessler II, Diamond EL (1971) Epidemiologic studies of Parkinson’s disease. I. Smoking and Parkinson’s disease: a survey and explanatory hypothesis. Am J Epidemiol 94: 16–25

    PubMed  CAS  Google Scholar 

  16. Kondo K (1984) Epidemiological clues for the etiology of Parkinson’s disease. Adv Neurol 40: 345–351

    PubMed  CAS  Google Scholar 

  17. Kondo K, Shibasaki H (1981) Epidemiology of Parkinson’s disease. Clues for etiology. 12th World congress of neurology, International Congress Series 548. Excerpta Medica, Amsterdam, p 233

    Google Scholar 

  18. Kurland LT (1958) Epidemiology: incidence geographic distribution and genetic considerations. In: Fields WJ (ed) Pathogenesis and treatment of Parkinsonism. Charles C. Thomas, Springfield, 111, pp 5–49

    Google Scholar 

  19. Kurtzke JF, Kurland LT (1981) The epidemiology of neurologic disease. In: Baker AB, Baker LH (eds) Clinical neurology, vol 3, chap 48. Harper and Row, New York

    Google Scholar 

  20. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980

    Article  PubMed  CAS  Google Scholar 

  21. Li S, Schoenberg BS, Wang C, Cheng X, Rui D, Bolis CL, Schoenberg DG (1985) A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China. Arch Neurol 42: 655–657

    PubMed  CAS  Google Scholar 

  22. Lipkin LE (1959) Cytoplasmic inclusions in ganglion cells associated with parkinsonian states: a neurocellular change studied in 53 cases and 206 controls. Am J Pathol 35: 1117–1133

    PubMed  CAS  Google Scholar 

  23. Maier Hoehn MM (1985) Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson’s disease. Acat Neurol Scand 71: 97–106

    Article  Google Scholar 

  24. Marttila RJ, Rinne UK (1976) Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand 53: 81–102

    Article  PubMed  CAS  Google Scholar 

  25. Marttila RJ, Rinne UK (1976) Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson’s disease. A case-control study. Clin Neurol Neurosurg 76: 46–56

    Article  Google Scholar 

  26. Marttila RJ, Rinne UK (1979) Changing epidemiology of Parkinson’s disease: predicted effects of levodopa treatment. Acta Neurol Scand 59: 80–87

    Article  PubMed  CAS  Google Scholar 

  27. Marttila RJ, Rinne UK (1980) Smoking and Parkinson’s disease. Acta Neurol Scand 62: 322–325

    Article  PubMed  CAS  Google Scholar 

  28. Marttila RJ, Rinne UK (1985) Clues from the epidemiology of Parkinson’s disease. Adv Neurol (in press)

    Google Scholar 

  29. Marttila RJ, Rinne UK, Siirtola T, Sonninen V (1977) Mortality of patients with Parkinson’s disease treated with levodopa. J Neurol 216: 147–153

    Article  PubMed  CAS  Google Scholar 

  30. Mutch W(1985) Parkinson’s disease in Aberdeen; 1983–1984. In: Social, epidemiological and therapeutic aspects of Parkinson’s disease. Abstracts. 5 Feb 1985, London

    Google Scholar 

  31. Nobrega FT, Glattre E, Kurland LT, Okazaki H (1969) Comments on the epidemiology of parkinsonism including prevalence and incidence statistics for Rochester, Minnesota, 1935–1966. In: Barbeau A, Brünetter JR (eds) Progress in neuro-genetics. Excerpta Medica, Amsterdam, pp 474–485

    Google Scholar 

  32. dePedro J, Rosenqvist U (1984) Tracers for paralysis agitans in epidemiological research. II. A model for indirect estimation of the prevalence of the disease. Neuroepid 3: 97–107

    Article  Google Scholar 

  33. Pollock M, Hornabrook RW (1966) The prevalence, natural history and dementia of Parkinson’s disease. Brain 89: 429–448

    Article  PubMed  CAS  Google Scholar 

  34. Poskanzer DC, Schwab RS (1963) Cohort analysis of Parkinson’s disease. Evidence for a single etiology related to subclinical infection about 1920. J Chron Dis 16: 961–973

    Article  PubMed  CAS  Google Scholar 

  35. Pritchard PB, Netsky MG (1973) Prevalence of neoplasms and causes of death in paralysis agitans. Neurology 23: 215–222

    PubMed  Google Scholar 

  36. Rajput AH, Offord KP, Beard CM, Kurland LT (1984) Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 16: 278–282

    Article  PubMed  CAS  Google Scholar 

  37. Reef HE (1977) Prevalence of Parkinson’s disease in a multiracial community. In: den Hartog Jager WA, Bruyn GW, Heijstee APJ (eds) 11th World congress of neurology. Excerpta Medica, Amsterdam, p 125

    Google Scholar 

  38. Rosati G, Granieri E, Pinna L, Aiello L, Tola R, De Bastini P, Pirisi A, Devoto MC (1980) The risk of Parkinson disease in Mediterranean people. Neurology 30: 250–255

    PubMed  CAS  Google Scholar 

  39. Schoenberg BS, Anderson DW, Haerer AF (1982) Differences by race in the prevalence of Parkinson’s disease. Abstracts of the 7th international symposium on Parkinson’s disease, 27–30 June 1982, Frankfurt a. M., p 55

    Google Scholar 

  40. Schoenberg BS, Anderson DW, Haerer AF (1985) Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology 35: 841–845

    PubMed  CAS  Google Scholar 

  41. Sweet RD, McDowell RH (1975) Five years’ treatment of Parkinson’s disease with levo- dopa. Ann Intern Med 83: 456–463

    PubMed  CAS  Google Scholar 

  42. Todes CJ, Lees AJ (1985) The pre-morbid personality of patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 48: 97–100

    Article  PubMed  CAS  Google Scholar 

  43. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB (1983) Parkinson’s disease in 65 pairs of twins and in a set of quadruplets. Neurology 33: 815–824

    PubMed  CAS  Google Scholar 

  44. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB, Dambrosia J (1984) Parkinson’s disease in twins. Adv Neurol 40: 341–344

    PubMed  CAS  Google Scholar 

  45. Yahr MD (1976) Evaluation of long-term therapy in Parkinson’s disease. Mortality and therapeutic efficacy. In: Birkmayer W, Hornykiewicz O (eds) Advances in Parkinsonism. Editiones Roche, Basle, pp 435–443

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Marttila, R.J., Rinne, U.K. (1986). Epidemiology of Parkinson’s Disease. In: Poeck, K., Freund, HJ., Gänshirt, H. (eds) Neurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70007-1_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70007-1_37

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70009-5

  • Online ISBN: 978-3-642-70007-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics